Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Alzheimer's Type Dementia”

177 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 177 results

Testing effectiveness (Phase 2)Study completedNCT01276353
What this trial is testing

A Study Versus E2020 10mg Followed by an Open-label Extension Phase to Explore the Safety of E2020 SR 23 mg in Japanese Subjects With Severe Alzheimer's Type Dementia

Who this might be right for
Alzheimer's Type Dementia
Eisai Inc. 45
Large-scale testing (Phase 3)Ended earlyNCT06424236
What this trial is testing

Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia: A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation

Who this might be right for
Alzheimers DiseaseDementiaAlzheimers Disease, Familial
Washington University School of Medicine 73
Testing effectiveness (Phase 2)Study completedNCT04971733
What this trial is testing

Assess Safety and Target Engagement of E2814 in Participants With Mild to Moderate Cognitive Impairment Due to Dominantly Inherited Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Eisai Inc. 8
Early research (Phase 1)Study completedNCT05328115
What this trial is testing

A Study on the Safety, Tolerability and Immunogenicity of ALZ-101 in Participants With Early Alzheimer's Disease

Who this might be right for
Alzheimer DiseaseDementia AlzheimersDementia, Mild
Alzinova AB 33
Large-scale testing (Phase 3)Study completedNCT04947553
What this trial is testing

Assess the Long-term Safety and Efficacy of AXS-05 in Subjects With Alzheimer's Disease Agitation

Who this might be right for
Agitation in Patients With Dementia of the Alzheimer's TypeAlzheimer DiseaseAgitation, Psychomotor
Axsome Therapeutics, Inc. 456
Testing effectiveness (Phase 2)Study completedNCT00842816
What this trial is testing

Preliminary Efficacy and Safety Study of ST101 Plus Aricept in Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Sonexa Therapeutics, Inc. 210
Large-scale testing (Phase 3)Study completedNCT04797715
What this trial is testing

Assessing Clinical Outcomes in Alzheimer's Disease Agitation

Who this might be right for
Agitation in Patients With Dementia of the Alzheimer's TypeAlzheimer DiseaseAgitation,Psychomotor
Axsome Therapeutics, Inc. 178
Large-scale testing (Phase 3)Study completedNCT00036114
What this trial is testing

Study of Aripiprazole in the Treatment of Patients With Psychosis Associated With Dementia of the Alzheimer's Type

Who this might be right for
Alzheimer Disease
Otsuka Pharmaceutical Development & Commercialization, Inc.
Not applicableActive Not RecruitingNCT03846492
What this trial is testing

Targeting Brain Physiology to Treat Neuropsychiatric Symptoms of Dementia Using TMS-EEG and tDCS

Who this might be right for
Alzheimer DiseaseDementia, MixedDementia+2 more
Centre for Addiction and Mental Health 90
Large-scale testing (Phase 3)Study completedNCT00428090
What this trial is testing

Rosiglitazone (Extended Release Tablets) As Monotherapy In Subjects With Mild To Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
GlaxoSmithKline 862
Not applicableStudy completedNCT04981587
What this trial is testing

Effects of Strength Exercise on Fall Risk in Elderly With Alzheimer's Disease

Who this might be right for
Alzheimer DiseaseDementia; Alzheimer's Type (Etiology)Fall Risk+2 more
University of Jaén 64
Not applicableStudy completedNCT06382194
What this trial is testing

Decision Making Tool for Firearm Storage

Who this might be right for
Dementia, MildDepression
University of Washington 5
Testing effectiveness (Phase 2)Study completedNCT01273272
What this trial is testing

Cognitive-Behavioral Treatment for Mild Alzheimer's Patients and Their Caregivers

Who this might be right for
Alzheimer Disease
University of Zurich 50
Early research (Phase 1)Study completedNCT02859207
What this trial is testing

Evaluate the Pharmacokinetics of E2609 and Its Metabolites in Subjects With Mild and Moderate Hepatic Impairment Compared With Healthy Subjects

Who this might be right for
Early Alzheimer's Disease
Eisai Inc. 32
Large-scale testing (Phase 3)Study completedNCT00322153
What this trial is testing

The Safety and Efficacy of Memantine in Moderate to Severe Alzheimer's Disease

Who this might be right for
Dementia of the Alzheimer's Type
Forest Laboratories 677
Large-scale testing (Phase 3)Ended earlyNCT02168920
What this trial is testing

Aripiprazole for the Treatment of Patients With Agitation Associated With Dementia of the Alzheimer's Type

Who this might be right for
Agitation Associated With Dementia of the Alzheimer's Type
Otsuka Pharmaceutical Co., Ltd. 150
Early research (Phase 1)Study completedNCT02502253
What this trial is testing

BDPP Treatment for Mild Cognitive Impairment (MCI) and Prediabetes or Type 2 Diabetes Mellitus (T2DM)

Who this might be right for
Mild Cognitive ImpairmentAlzheimer's Disease
Johns Hopkins University 14
Large-scale testing (Phase 3)Study completedNCT03721705
What this trial is testing

Renew NCP-5 for the Treatment of Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild Dementia of the Alzheimer's Type

Who this might be right for
Alzheimer DiseaseCognitive DysfunctionMild Cognitive Impairment+3 more
Renew Research, LLC 190
Large-scale testing (Phase 3)Study completedNCT03393520
What this trial is testing

Assessment of the Efficacy, Safety, and Tolerability of AVP-786 (Deudextromethorphan Hydrobromide [d6-DM]/Quinidine Sulfate [Q]) for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type

Who this might be right for
Agitation in Patients With Dementia of the Alzheimer's Type
Otsuka Pharmaceutical Development & Commercialization, Inc. 601
Large-scale testing (Phase 3)Study completedNCT04623242
What this trial is testing

Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation.

Who this might be right for
Alzheimers DiseaseDementiaAlzheimers Disease, Familial
Washington University School of Medicine 194
Load More Results